BioPharma Dive 24. Nov. 2025 Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies #Novo Nordisk #watched Alzheimer
BioPharma Dive 24. Nov. 2025 APOE4 and CRISPR are reframing Alzheimer’s Risk #reframing Alzheimer #CRISPR brings